Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
Aspen Pharmacare Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 12
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 13
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deal Details 16
Asset Purchase 16
Aspen to Acquire Remaining Rights to Anaesthetic Portfolio from Astrazeneca 16
Aspen Japan Acquires Four Ethical Drug Brands from Kyowa Hakko Kirin 17
Aspen Pharmacare Acquires Anaesthesia Portfolio from GlaxoSmithKline 18
Aspen Global to Acquire Rights to Hydroxyprogesterone Caproate Injection form McGuff Pharma 19
Aspen Pharmacare Acquires Southern African Operations and Product Rights from Norgine 20
Aspen Pharmacare Plans to Acquire Infant Nutrition Business 21
Aspen Pharmacare Acquires Rights to Mono-Embolex from Novartis 22
Aspen Pharma Acquires Infant Nutritional Businesses from Nestle for USD180 Million 23
Aspen Pharmacare Completes Acquisition of Thrombosis Brands And Manufacturing Facility from GlaxoSmithKline for USD1.13 Billion 25
Aspen Acquires Active Pharmaceutical Ingredients Business From Merck 27
Aspen Completes Acquisition Of Non-Core Australian Drugs From GlaxoSmithKline For US$257 Million 28
Aspen Pharmacare Completes Acquisition Of Non-Core OTC Brands From GlaxoSmithKline For US$263 Million 31
Partnerships 33
Aspen Pharmacare Holdings to Enter into Research Agreement with Far Eastern Federal University 33
AstraZeneca Enters into Co-Marketing Agreement with Aspen 34
ANI Pharma Enters into Distribution Agreement with Aspen 35
Cardiome Pharma Enters into Co-Marketing Agreement with Aspen Pharma for Brinavess 36
Navamedic Amends Distribution Agreement With Aspen Pharma 37
Cipla Plans To Enters Into Co-Development Agreement With Aspen Pharmacare 38
Licensing Agreements 39
Aspen Pharmacare Australia Enters into Licensing Agreement with Neurim Pharma 39
Aspen Pharma Enters into Licensing Agreement with Starpharma 40
Iroko Pharma Enters into Licensing Agreement with Aspen Pharma for Zorvolex 41
TesoRx Pharma Enters into Licensing Agreement with Aspen Global 42
QRxPharma Enters Into Licensing Agreement With Aspen Pharma For Moxduo 43
QRxPharma Exercises Option For Licensing Agreement With Aspen Pharma For Moxduo 44
Equity Offering 45
Aspen Pharmacare Raises USD624 Million in Private Placement of Shares 45
Asset Transactions 47
Endo International Acquires Portfolio of Branded and Generic Products 47
Strides Arcolab Acquires Prescription Products from Aspen Global for USD92 million 48
Strides Arcolab Acquires Generic Pharma Business and Related Assets from Aspen Pharmacare for USD210 Million 49
Aspen Pharmacare to Divest Business Unit to Litha Pharma for USD134 Million 50
Mylan to Acquire Rights to Arixtra Injection from Aspen Global 51
Perrigo Acquires OTC Products From Aspen Global For US$51 Million 52
Acquisition 53
GlaxoSmithKline to Acquire 25% Stake in Aspen Japan 53
GlaxoSmithKline Completes Sale Of 6.19% Stake In Aspen Pharmacare For US$696.5 Million 54
Aspen Pharmacare Completes Acquisition Of Remaining 40% Stake In Shelys Africa For US$18.6 Million 55
Aspen Pharmacare Holdings Ltd – Key Competitors 56
Aspen Pharmacare Holdings Ltd – Key Employees 57
Aspen Pharmacare Holdings Ltd – Locations And Subsidiaries 58
Head Office 58
Other Locations & Subsidiaries 58
Joint Venture 61
Recent Developments 62
Financial Announcements 62
Mar 08, 2018: Aspen delivers double digit revenue and earnings growth 62
Sep 14, 2017: Aspen increases revenue by 16% to R41.2 billion 65
Mar 09, 2017: Aspen: Unaudited interim financial results for the six months ended 31 December 2016 68
Legal and Regulatory 71
Jun 13, 2017: Aspen: South African Competition Commission Announcement 71
May 15, 2017: Aspen: Opening of European Commission proceedings 72
Apr 24, 2017: Aspen’s response to the reported Competition Commission investigation 73
Government and Public Interest 74
May 29, 2017: Aspen Cleared of Alleged Anti-competitive Behavior by DA 74
May 15, 2017: Antitrust: Commission opens formal investigation into Aspen Pharma’s pricing practices for cancer medicines 75
Other Significant Developments 77
Oct 26, 2018: Aspen’s participation in the 2018 Investment Conference 77
Mar 01, 2017: Aspen – Trading Statement 78
Appendix 79
Methodology 79
About GlobalData 79
Contact Us 79
Disclaimer 79
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Aspen Pharmacare Holdings Ltd, Deals By Therapy Area, 2012 to YTD 2018 10
Aspen Pharmacare Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 12
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 13
Aspen to Acquire Remaining Rights to Anaesthetic Portfolio from Astrazeneca 16
Aspen Japan Acquires Four Ethical Drug Brands from Kyowa Hakko Kirin 17
Aspen Pharmacare Acquires Anaesthesia Portfolio from GlaxoSmithKline 18
Aspen Global to Acquire Rights to Hydroxyprogesterone Caproate Injection form McGuff Pharma 19
Aspen Pharmacare Acquires Southern African Operations and Product Rights from Norgine 20
Aspen Pharmacare Plans to Acquire Infant Nutrition Business 21
Aspen Pharmacare Acquires Rights to Mono-Embolex from Novartis 22
Aspen Pharma Acquires Infant Nutritional Businesses from Nestle for USD180 Million 23
Aspen Pharmacare Completes Acquisition of Thrombosis Brands And Manufacturing Facility from GlaxoSmithKline for USD1.13 Billion 25
Aspen Acquires Active Pharmaceutical Ingredients Business From Merck 27
Aspen Completes Acquisition Of Non-Core Australian Drugs From GlaxoSmithKline For US$257 Million 28
Aspen Pharmacare Completes Acquisition Of Non-Core OTC Brands From GlaxoSmithKline For US$263 Million 31
Aspen Pharmacare Holdings to Enter into Research Agreement with Far Eastern Federal University 33
AstraZeneca Enters into Co-Marketing Agreement with Aspen 34
ANI Pharma Enters into Distribution Agreement with Aspen 35
Cardiome Pharma Enters into Co-Marketing Agreement with Aspen Pharma for Brinavess 36
Navamedic Amends Distribution Agreement With Aspen Pharma 37
Cipla Plans To Enters Into Co-Development Agreement With Aspen Pharmacare 38
Aspen Pharmacare Australia Enters into Licensing Agreement with Neurim Pharma 39
Aspen Pharma Enters into Licensing Agreement with Starpharma 40
Iroko Pharma Enters into Licensing Agreement with Aspen Pharma for Zorvolex 41
TesoRx Pharma Enters into Licensing Agreement with Aspen Global 42
QRxPharma Enters Into Licensing Agreement With Aspen Pharma For Moxduo 43
QRxPharma Exercises Option For Licensing Agreement With Aspen Pharma For Moxduo 44
Aspen Pharmacare Raises USD624 Million in Private Placement of Shares 45
Endo International Acquires Portfolio of Branded and Generic Products 47
Strides Arcolab Acquires Prescription Products from Aspen Global for USD92 million 48
Strides Arcolab Acquires Generic Pharma Business and Related Assets from Aspen Pharmacare for USD210 Million 49
Aspen Pharmacare to Divest Business Unit to Litha Pharma for USD134 Million 50
Mylan to Acquire Rights to Arixtra Injection from Aspen Global 51
Perrigo Acquires OTC Products From Aspen Global For US$51 Million 52
GlaxoSmithKline to Acquire 25% Stake in Aspen Japan 53
GlaxoSmithKline Completes Sale Of 6.19% Stake In Aspen Pharmacare For US$696.5 Million 54
Aspen Pharmacare Completes Acquisition Of Remaining 40% Stake In Shelys Africa For US$18.6 Million 55
Aspen Pharmacare Holdings Ltd, Key Competitors 56
Aspen Pharmacare Holdings Ltd, Key Employees 57
Aspen Pharmacare Holdings Ltd, Other Locations 58
Aspen Pharmacare Holdings Ltd, Subsidiaries 58
Aspen Pharmacare Holdings Ltd, Joint Venture 61
List of Figures
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 8
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
Aspen Pharmacare Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 12